Cari soci Ance ho il piacere e l’onore , come anticipato alla riunione dei nostri quadri tenutasi il 22/23 aprile , di comunicarvi l’avvio di un importante studio, in cooperazione con l’AIAC, sulla fibrillazione atriale: lo studio FACT . A fine maggio...
Abstract Background Risk stratification in asymptomatic patients remains by far the most important yet unresolved clinical problem in the Brugada syndrome (BrS). Objectives This study sought to analyze the usefulness of electrocardiographic parameters as markers...
Most physician readers of Aro’s and Chugh’s elegant review of electrical and anatomic types of LVH and the implications will be puzzled by the concepts that electrical LVH (ECG/LVH) and anatomic LVH (echo/LVH and MRI/LVH) might be different entities, and that...
Patients with heart failure have a poor prognosis, yet outcomes might be improved by early identification of risk. Proenkephalin (proENK), a novel biomarker, is a stable surrogate marker for endogenous enkephalins and is an independent predictor of heart failure...
We aim to evaluate the potential benefit and risk of addition of vorapaxar to standard medical therapy in patients who underwent coronary revascularization with either percutaneous coronary revascularization or coronary artery bypass graft surgery. We searched...
Dopo l’endorsement dei giorni scorsi ricevuto dello staff interno dell’Fda, lo scorso 15 gennaio il nuovo antiaggregante orale vorapaxar ha ricevuto il parere positivo degli esperti del Cardiovascular and Renal Drugs Advisory Committee dell’Fda. Con 10 voti a 1,...
Objectives The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete...
Allopurinol lowers blood pressure in adolescents and has other vasoprotective effects. Whether similar benefits occur in older individuals remains unclear. We hypothesized that allopurinol is associated with improved cardiovascular outcomes in older adults with...
Si è concluso Giovedì 4 Febbraio il “Convention Consensus Document Intersocietaria”, tenutosi a Catania su iniziativa dell’A.N.M.C.O., che ha visto riunite le più importanti società scientifiche di area medica, di farmacologia, di biochimica clinica e di biologia...
Background Diagnosed diabetes mellitus (DM) is a consistently documented risk factor for ischemic stroke in patients with atrial fibrillation (AF). Objectives The purpose of this study was to assess the association between duration of diabetes and elevated...
This investigation sought to quantify the risk factors for short-term readmission in patients with heart failure (HF). Electronic databases were systematically searched for studies reporting relative risk, odds ratio, and hazard ratio for the combined primary...
Adiponectin is a key component in multiple metabolic pathways. Studies evaluating associations of adiponectin with clinical outcomes in older adults have reported conflicting results. We investigated the association of adiponectin with mortality and cardiovascular...
The American Journal of Cardiology Alcohol use, physical activity, diet, and cigarette smoking are modifiable cardiovascular risk factors that have a substantial impact on the risk of myocardial infarction, stroke, and cardiovascular death. We hypothesized that...
Journal of the American College of Cardiology Background Although recommended in guidelines for the management of coronary heart disease (CHD), concerns have been raised about the applicability of evidence from existing meta-analyses of exercise-based cardiac...
The American Journal of Cardiology Takotsubo cardiomyopathy (TC) often occurs after emotional or physical stress. Norepinephrine levels are unusually high in the acute phase, suggesting a hyperadrenergic mechanism. Comparatively little is known about...
Abstract Background We recently reported that normal aldosterone levels are associated with cardiovascular, renal, and metabolic disease in a sample of the US general community (Visit 1). For the current analyses we used the same cohort in a new 4‐year follow‐up...
Summary Background The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well established. However, the extent to which these effects differ by baseline blood pressure, presence of comorbidities, or drug class is less clear....
Lo studio IMPROVE-IT non ha evidenziato alcun beneficio in endpoint clinicamente importanti e non manipolabili All’Editor. Negli ultimi 20 anni, l’endpoint primario di trial randomizzati che studiavano gli effetti di farmaci ipolipemizzanti si è spostato dalla...
Il nuovo studio.SPRINT docx curato da Peppino Calcaterra
The authors of this study evaluated the effectiveness of CHA2DS2-VASc and CHADS2 scores compared with ATRIA score for predicting stroke risk in 60,594 patients with atrial fibrillation not on warfarin. The ATRIA score had a C statistic of 0.70, which was slightly...
